Impact of Non-Invasive Prenatal Genetic Screening and Genetic Counseling with Sheetal Parmar Natera TRANSCRIPT
Download PDFMar 20, 2022
Sheetal Parmar is the Head of Clinical Services at Natera, a clinical genetic testing company. She draws on her experience as a prenatal genetic counselor to address the need for more accurate and available non-invasive prenatal genetic testing. This kind of information can guide women and their care teams and can also...
Mar 20, 2022
Sheetal Parmar is the Head of Clinical Services at Natera, a clinical genetic testing company. She draws on her experience as a prenatal genetic counselor to address the need for more accurate and available non-invasive prenatal genetic testing. This kind of information can guide women and their care teams and can also...
Oct 21, 2020
Bernard Gilly PhD, CEO and Co-Founder, GenSight Biologics talks about the innovative gene therapy treatments GenSight is developing to fight blinding diseases. Bernard sheds light on treating Leber Hereditary Optic Neuropathy (LHON), a mitochondrial rare disease as well as retinitis pigmentosa (RP). Their goal is to...
Oct 21, 2020
Bernard Gilly PhD, CEO and Co-Founder, GenSight Biologics talks about the innovative gene therapy treatments GenSight is developing to fight blinding diseases. Bernard sheds light on treating Leber Hereditary Optic Neuropathy (LHON), a mitochondrial rare disease as well as retinitis pigmentosa (RP). Their goal is to...
May 30, 2017
Jason Shelton, CEO, Telomere Diagnostics and developer of TeloYears is bringing to market a way to measure the health of the cells in our body. Using a blood test to determine the length of the telomeres at the end of the chromosomes, a person's TeloYears is computed and compared to others of the same chronological...